Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: Experience in renal allograft transplantation

Human Immunology

Volumn 66, Issue 4, 2005, Pages 350-358

  Lehrich, Ruediger W ^a   Rocha, Paulo N ^b   Reinsmoen, Nancy ^a   Greenberg, Arthur ^a   Butterly, David W ^a   Howell, David N ^a   Smith, Stephen R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Acute humoral rejection; allograft survival; Intravenous immunoglobulin; plasmapheresis; Renal allografts

Indexed keywords

IMMUNOGLOBULIN; OKT 3; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; INCIDENCE; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; SURVIVAL; TREATMENT OUTCOME;

EID: 18144382600     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2005.01.028     Document Type: Article

References (41)

1. J.L. Platt Acute vascular rejection Transplant Proc 32 2000 839
2. M. Jeannet, V.W. Pinn, M.H. Flax, H.J. Winn, P.S. Russell Humoral antibodies in renal allotransplantation in man N Engl J Med 282 1970 111
3. P.F. Halloran, A. Wadgymar, S. Ritchie, J. Falk, K. Solez, N.S. Srinivasa The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection Transplantation 49 1990 85
4. S. Saadi, R.A. Holzknecht, C.P. Patte, D.M. Stern, J.L. Platt Complement-mediated regulation of tissue factor activity in endothelium J Exp Med 182 1995 1807
5. J.L. Platt, G.M. Vercellotti, A.P. Dalmasso, A.J. Matas, R.M. Bolman, J.S. Najarian, F.H. Bach Transplantation of discordant xenografts a review of progress Immunol Today 11 1990 450
6. S. Mauiyyedi, R.B. Colvin Humoral rejection in kidney transplantation new concepts in diagnosis and treatment Curr Opin Nephrol Hypertens 11 2002 609
7. M. Crespo, M. Pascual, N. Tolkoff-Rubin, S. Mauiyyedi, A.B. Collins, D. Fitzpatrick, M.L. Farrell, W.W. Williams, F.L. Delmonico, A.B. Cosimi, R.B. Colvin, S.L. Saidman Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics Transplantation 71 2001 652
8. K. Trpkov, P. Campbell, F. Pazderka, S. Cockfield, K. Solez, P.F. Halloran Pathologic features of acute renal allograft rejection associated with donor-specific antibody analysis using the Banff grading schema Transplantation 61 1996 1586
9. P.I. Lobo, C.E. Spencer, W.C. Stevenson, T.L. Pruett Evidence demonstrating poor kidney graft survival when acute rejections are associated with IgG donor-specific lymphocytotoxin Transplantation 59 1995 357
10. P.N. Rocha, D.W. Butterly, A. Greenberg, D.N. Reddan, J. Tuttle-Newhall, B.H. Collins, P.C. Kuo, N. Reinsmoen, T. Fields, D.N. Howell, S.R. Smith Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection Transplantation 75 2003 1490
11. N.B. White, S.M. Greenstein, A.W. Cantafio, R. Schechner, D. Glicklich, P. McDonough, J. Pullman, K. Mohandas, F. Boctor, J. Uehlinger, V. Tellis Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection Transplantation 78 2004 772
12. B. Grandtnerova, P. Javorsky, J. Kolacny, B. Hovoricova, P. Dedic, L. Laca Treatment of acute humoral rejection in kidney transplantation with plasmapheresis Transplant Proc 27 1995 934
13. G.A. Bohmig, H. Regele, M. Exner, V. Derhartunian, J. Kletzmayr, M.D. Saemann, W.H. Horl, W. Druml, B. Watschinger C4d-positive acute humoral renal allograft rejection effective treatment by immunoadsorption J Am Soc Nephrol 12 2001 2482
14. M.D. Kazatchkine, S.V. Kaveri Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin N Engl J Med 345 2001 747
15. Y. Sultan, M.D. Kazatchkine, P. Maisonneuve, U.E. Nydegger Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin Lancet 324 1984 755
16. C. Xu, B. Poirier, J.P. Van Huyen, N. Lucchiari, O. Michel, J. Chevalier, S. Kaveri Modulation of endothelial cell function by normal polyspecific human intravenous immunoglobulins a possible mechanism of action in vascular diseases Am J Pathol 153 1998 1257
17. W. Stohl Cellular mechanisms in the in vitro inhibition of pokeweed mitogen-induced B cell differentiation by immunoglobulin for intravenous use J Immunol 136 1986 4407
18. M. Toyoda, X. Zhang, A. Petrosian, O.A. Galera, S.J. Wang, S.C. Jordan Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin J Clin Immunol 14 1994 178
19. I.N. van Schaik, I. Lundkvist, M. Vermeulen, A. Brand Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro J Clin Immunol 12 1992 325
20. M. Toyoda, A. Pao, A. Petrosian, S.C. Jordan Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells Am J Transplant 3 2003 156
21. L.C. Racusen, K. Solez, R.B. Colvin, S.M. Bonsib, M.C. Castro, T. Cavallo, B.P. Croker, A.J. Demetris, C.B. Drachenberg, A.B. Fogo, P. Furness, L.W. Gaber, I.W. Gibson, D. Glotz, J.C. Goldberg, J. Grande, P.F. Halloran, H.E. Hansen, B. Hartley, P.J. Hayry, C.M. Hill, E.O. Hoffman, L.G. Hunsicker, A.S. Lindblad, N. Marcussen, M.J. Mihatsch, T. Nadasdy, P. Nickerson, T.S. Olsen, J.C. Papadimitriou, P.S. Randhawa, D.C. Rayner, I. Roberts, S. Rose, D. Rush, L. Salinas-Madrigal, D.R. Salomon, S. Sund, E. Taskinen, K. Trpkov, Y. Yamaguchi The Banff 97 working classification of renal allograft pathology Kidney Int 55 1999 713
22. L.C. Racusen, R.B. Colvin, K. Solez, M.J. Mihatsch, P.F. Halloran, P.M. Campbell, M.J. Cecka, J.P. Cosyns, A.J. Demetris, M.C. Fishbein, A. Fogo, P. Furness, I.W. Gibson, D. Glotz, P. Hayry, L. Hunsickern, M. Kashgarian, R. Kerman, A.J. Magil, R. Montgomery, K. Morozumi, V. Nickeleit, P. Randhawa, H. Regele, D. Seron, S. Seshan, S. Sund, K. Trpkov Antibody-mediated rejection criteria--an addition to the Banff 97 classification of renal allograft rejection Am J Transplant 3 2003 708
23. R. Pei, G. Wang, C. Tarsitani, S. Rojo, T. Chen, S. Takemura, A. Liu, J. Lee Simultaneous HLA class I and class II antibodies screening with flow cytometry Hum Immunol 59 1998 313
24. S. Mauiyyedi, M. Crespo, A.B. Collins, E.E. Schneeberger, M.A. Pascual, S.L. Saidman, N.E. Tolkoff-Rubin, W.W. Williams, F.L. Delmonico, A.B. Cosimi, R.B. Colvin Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification J Am Soc Nephrol 13 2002 779
25. B. Watschinger, M. Pascual Capillary C4d deposition as a marker of humoral immunity in renal allograft rejection J Am Soc Nephrol 13 2002 2420
26. J.C. Scornik, D.R. Salomon, P.B. Lim, R.J. Howard, W.W. Pfaff Posttransplant antidonor antibodies and graft rejection evaluation by two-color flow cytometry Transplantation 47 1989 287
27. R. Fredrich, M. Toyoda, L.S. Czer, K. Galfayan, O. Galera, A. Trento, D. Freimark, S. Young, S.C. Jordan The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation Transplantation 67 1999 385
28. S. Sumitran-Holgersson, H.E. Wilczek, J. Holgersson, K. Soderstrom Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts Transplantation 74 2002 268
29. D. Dragun, D.N. Müller, J.H. Bräsen, L. Fritsche, M. Nieminen-Kelhä, R. Dechend, U. Kintscher, B. Rudolph, J. Hoebeke, D. Eckert, I. Mazak, R. Plehm, C. Schönemann, T. Unger, K. Budde, H.H. Neumayer, F.C. Luft, G. Wallukat Angiotensin II Type 1-Receptor Activating Antibodies in Renal-Allograft Rejection N Engl J Med 352 2005 558
30. V. Hurez, S.V. Kaveri, M.D. Kazatchkine Expression and control of the natural autoreactive IgG repertoire in normal human serum Eur J Immunol 23 1993 783
31. A. Sundblad, M.A. Marcos, E. Malanchere, A. Castro, M. Haury, F. Huetz, A. Nobrega, A. Freitas, A. Coutinho Observations on the mode of action of normal immunoglobulin at high doses Immunol Rev 139 1994 125
32. T. Vassilev, M. Yamamoto, A. Aissaoui, E. Bonnin, S. Berrih-Aknin, M.D. Kazatchkine, S.V. Kaveri Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice Eur J Immunol 29 1999 2436
33. M.B. Adams, H.M. Kauffman Jr, L.A. Hebert, C.V. Hussey, R.J. Duquesnoy, P.A. Tomasulo Plasmapheresis in the treatment of renal allograft rejection Proc Clin Dial Transplant Forum 9 1979 252
34. E. Akalin, S. Ames, V. Sehgal, M. Fotino, L. Daly, B. Murphy, J.S. Bromberg Intravenous immunoglobulin and Thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients Transplantation 76 2003 1444
35. J.M. Aranda Jr, J.C. Scornik, S.J. Normann, R. Lottenberg, R.S. Schofield, D.F. Pauly, M. Miles, J.A. Hill, J.W. Sleasman, S. Skoda-Smith Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection a case report Transplantation 73 2002 907
36. H.E. Garrett Jr, K. Groshart, D. Duvall-Seaman, D. Combs, R. Suggs Treatment of humoral rejection with rituximab Ann Thorac Surg 74 2002 1240
37. S.C. Jordan, A. Vo, S. Bunnapradist, M. Toyoda, A. Peng, D. Puliyanda, E. Kamil, D. Tyan Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients Transplantation 76 2003 631
38. R.A. Montgomery, A.A. Zachary, L.C. Racusen, M.S. Leffell, K.E. King, J. Burdick, W.R. Maley, L.E. Ratner Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients Transplantation 70 2000 887
39. C.J. Sonnenday, L.E. Ratner, A.A. Zachary, J.F. Burdick, M.D. Samaniego, E. Kraus, D.S. Warren, R.A. Montgomery Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match Transplant Proc 34 2002 1614
40. J.M. Gloor, S.R. DeGoey, A.A. Pineda, S.B. Moore, M. Prieto, S.L. Nyberg, T.S. Larson, M.D. Griffin, S.C. Textor, J.A. Velosa, T.R. Schwab, L.A. Fix, M.D. Stegall Overcoming a positive crossmatch in living-donor kidney transplantation Am J Transplant 3 2003 1017
41. J.M. Gloor, S. DeGoey, N. Ploeger, H. Gebel, R. Bray, S.B. Moore, P.G. Dean, M.D. Stegall Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation Transplantation 78 2004 221